@innovativegenomics.bsky.social
Using genome engineering to solve humanity’s greatest problems in health, climate & sustainable agriculture. UC Berkeley, UCSF, UC Davis. https://innovativegenomics.org/
@natashaloder.bsky.social
Health Editor, The Economist. #Science #medicine #health, aspiring optimist, omnivorous information eater, mother of dragons. Free words at: Overmatter.substack.com
@antonioregalado.bsky.social
Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc.
@jacobplieth.bsky.social
Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@suedh.bsky.social
Doctor, drug developer, public health leader, runner; fan of Niners, Warriors & Giants.
@biosurgerysven.bsky.social
Surgeon, VC and strategic consultant experienced in developing Cell & Gene Therapies. When not trail running do a little traveling too....
@emilymullin.bsky.social
Science writer @wired.com, covering health and biotech Contact me: [email protected] or emullin.06 on Signal
@pennmedicine.bsky.social
This is the official account for Penn Medicine, the University of Pennsylvania Health System.
@pennmedcso.bsky.social
Chief Scientific Officer for Penn Medicine. This account is maintained by staff in the Office of the CSO. http://bit.ly/2gbO0s4
@aaronmring.bsky.social
Associate Professor and Anderson Family Chair of Immunotherapy, Fred Hutchinson Cancer Center Studying #cytokines, (auto)antibodies, and #cancerimmunotherapy. Founder: Simcha Tx, Seranova Bio, & Stipple Bio
@elizsmckenna.bsky.social
Executive Editor of Cancer Discovery, published by AACR. Harvard BBS/Dana-Farber alum. Native New Yorker. Posts are my own. She/her https://aacrjournals.org/cancerdiscovery
@drannanz.bsky.social
Immunologist | Flow Cytometrist Immunometabolism, Infectious Diseases, Immune dysfunction, Long Covid & ME/CFS Senior Research Fellow Liggins Institute | University of Auckland DysImmune Research Aotearoa www.dysimmune.nz 🇳🇿🥝🩸🧬🧪🔬👩🏼🔬
@richardsever.bsky.social
Co-Founder, bioRxiv and medRxiv. Assistant Director, Cold Spring Harbor Laboratory Press.
@mmolteni.bsky.social
Writing about CRISPR, synthetic bio, reprotech and neuroscience for @statnews. Ex-WIRED. Berkeley journalism alum. Signal: mmolteni.13 ✉️ [email protected] https://www.statnews.com/
@kaufm020.bsky.social
Professor @UCSD working on stem cells, NK cells, cell therapy and hematology. Golf and baseball also important. kaufmanlab.ucsd.edu
@nam.edu
Health for everyone, everywhere. Independent, evidence-based advisor in biomedical science, health, medicine, & related policy.
@tcellsrus.bsky.social
https://bit.ly/NIHfunding2025 T Cell Therapist..b/c T cells have unresolved issues 🇨🇦 Professor, A Cancer Center in Houston,TX Founder, Mongoose Bio 1st User, T cell hand sign 🫳+🫸 tcellsrus.com/respect-the-immune-system “another kalsarikänni day here WFH”
@penncancer.bsky.social
Penn Medicine - Abramson Cancer Center has proudly been an NCI-designated Comprehensive Cancer Center since 1973.
@biorxiv-immuno.bsky.social
@jonathanwosen.bsky.social
West Coast Biotech & Life Sciences Reporter for Stat News. Stanford Immunology PhD & UCSC SciCom alum. Tips? [email protected]. Signal: jwosen.27
@rowanwalrath.bsky.social
Life sciences reporter @cenmag.bsky.social. Texan Bostonian. Vaxed & masked. she/her. [email protected]. For sensitive tips, I'm on Signal @rowanwalrath.01 or email [email protected]
@arsalan.endpoints.news
Founder/CEO of Endpoints News (acquired by the Financial Times). Lawrence, Kansas-based aviator. Sharing occasional biopharma news biz takes and cockpit views. @AKAarsalan on twitter
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine [email protected]
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@reportergoodman.bsky.social
I'm a senior news writer on the health team at CNN. I cover medicine, policy, pharma, and healthcare. Need to reach me? Encrypted email: [email protected]
@carinastorrs.bsky.social
NYC-based science and health journalist and writer. Always interested in infectious diseases. Also on about equity in science and healthcare. Mom to human and cats.
@carolinechen.bsky.social
Investigative journalist covering health care @ProPublica. 香港人. Reach me at [email protected],
@aniloza.bsky.social
science journalist @stat | also: npr, nature, sciam, science, science news covering health equity, neuroscience, and interaction btwn science & society (he/him) (signal: aniloza.16)
@bobjherman.bsky.social
Health care business reporter for @statnews.com and its Health Care Inc. newsletter. Contact: [email protected] or bobjherman.09 on Signal. Sign up: https://www.statnews.com/signup/health-care-inc/
@lizszabo.bsky.social
She/her. Award-winning independent health journalist covering medical news for The New York Times, NBC News, Scientific American, AARP and others. Loves dogs and cats.
@sarahkarlin-smith.bsky.social
Journalist covering intersection of pharma, health policy & politics for the Pink Sheet. On Signal at SarahKarlinSmith.34 KFF Health News’ ‘What The Health?’ panelist. Co-created Prescription PULSE at Politico. GWU alum, dabbled in SMPA adjunct-ness.
@thealexknapp.bsky.social
Senior Editor covering science and healthcare at Forbes. (he/him) Got a tip? Hit me up on Signal: thealexknapp.79 "Eppur si muove"
@benthefidler.bsky.social
Biotech journalist; Senior Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy. #BioSky
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@jasonmast.bsky.social
Covering science, medicine & business for STAT Reach out on Signal: JasonMast.05
@natcancer.nature.com
Publishing the latest advances across all areas of cancer research and oncology. Part of @natureportfolio.nature.com 🌐 www.nature.com/natcancer/ 📍New York, London, Berlin and Heidelberg
@amarkelkar.bsky.social
BMT, Gene Therapy, & Hematology Physician at Dana-Farber Cancer Institute, Brigham & Women's Hospital, and Harvard Medical School | AI, Health Policy, Health Economics, & Ethics research | T.H. Chan Harvard MPH ‘23 | SGU '15 | Cornell ‘10
@fredlemaistre.bsky.social
Recently retired as SVP of Sarah Cannon Cancer Network . Past President of ASTCT.org and FACTweb.org. Masters swimmer
@simone-minnie.bsky.social
Assistant Professor @ UCSF| Myeloma, BMT, Immunotherapy Research
@bmtdrnemecek.bsky.social
Pediatric/AYA BMT & Cell Therapy, Clinical Researcher, Health Equity and Access physician advocate, proud Puerto Rican and citizen of the world.
@transplantdoc.bsky.social